Moreover, TFE3 gene fusions have been identified in patients with alveolar soft part sarcoma, epithelioid hemangioendothelioma and hepatic perivascular epithelioid cell tumors [26–28]. This evidence concerns the gene TFE3 and alveolar soft part sarcoma.